Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06842472
What this trial is testing

PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast Cancer

Who this might be right for
Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT02755272
What this trial is testing

Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer

Who this might be right for
Carcinoma Breast Stage IV
Fox Chase Cancer Center 87
Not applicableNot Yet RecruitingNCT07589972
What this trial is testing

Neoadjuvant Trastuzumab, Pertuzumab Plus Metronomic Vinorelbine for Elderly HER2-Positive Breast Cancer

Who this might be right for
Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04430595
What this trial is testing

Multi-4SCAR-T Therapy Targeting Breast Cancer

Who this might be right for
Breast Cancer
Shenzhen Geno-Immune Medical Institute 100
Testing effectiveness (Phase 2)Ended earlyNCT01319539
What this trial is testing

MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+11 more
National Cancer Institute (NCI) 12
Not applicableWithdrawnNCT00934401
What this trial is testing

Positron Emission Mammography With Fluorothymidine (FLT) to Evaluate Treatment Response to Chemotherapy in Breast Cancer

Who this might be right for
Breast Neoplasms
University of Iowa
Not applicableStudy completedNCT04629612
What this trial is testing

Regional Anesthesia in Breast Surgery

Who this might be right for
Breast NeoplasmsPainAnalgesia+1 more
Taipei Veterans General Hospital, Taiwan 120
Not applicableUnknownNCT01891123
What this trial is testing

Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy

Who this might be right for
Non-small Cell Lung CancerBreast CancerNasal Cancer
Sun Yat-sen University 300
Testing effectiveness (Phase 2)Looking for participantsNCT07288359
What this trial is testing

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Who this might be right for
Advanced HR+/HER2- Breast CancerAdvanced CCNE1-amplified Solid TumorsMetastatic Castration-resistant Prostate Cancer
Novartis Pharmaceuticals 205
Not applicableStudy completedNCT05927246
What this trial is testing

Radiotherapy-Associated Atrial Fibrillation

Who this might be right for
Atrial Fibrillation New Onset
Istanbul University 400
Large-scale testing (Phase 3)Study completedNCT00046527
What this trial is testing

Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsMetastases, Neoplasm
Celgene Corporation 460
Not applicableStudy completedNCT07355569
What this trial is testing

The Effect on Attendance of an SMS Notification Prior to a Scheduled Screening Appointment in BreastScreen Norway

Who this might be right for
AttendanceBreast Cancer Screening
Norwegian Institute of Public Health 133,770
Early research (Phase 1)Study completedNCT02683083
What this trial is testing

Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry and Tumor Imaging Potential of [131I]-SGMIB Anti-HER2 VHH1 in Healthy Volunteers and Breast Cancer Patients

Who this might be right for
Healthy VolunteersBreast Cancer
Precirix 9
Not applicableUnknownNCT06496724
What this trial is testing

A Clinical Study of Albumin-bound Paclitaxel/Granulocyte-based Therapy for Recurrent/Metastatic Breast Cancer

Who this might be right for
Breast Cancer
JIANG LONGWEI 1
Not applicableStudy completedNCT02302196
What this trial is testing

Autologous Fat Grafting of the Breast in Women With Post Lumpectomy Contour Defects

Who this might be right for
Cancer of the BreastAnomaly of Breast
Kaiser Permanente 27
Testing effectiveness (Phase 2)Looking for participantsNCT06897488
What this trial is testing

EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 300
Testing effectiveness (Phase 2)Study completedNCT01603303
What this trial is testing

Preventing Sexual Dysfunction With Aromatase Inhibitors

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 187
Large-scale testing (Phase 3)Looking for participantsNCT07057427
What this trial is testing

Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer

Who this might be right for
Breast Cancer
Henan Cancer Hospital 812
Large-scale testing (Phase 3)Study completedNCT00005970
What this trial is testing

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

Who this might be right for
Breast AdenocarcinomaHER2 Positive Breast CarcinomaStage IA Breast Cancer AJCC v7+4 more
National Cancer Institute (NCI) 3,436
Testing effectiveness (Phase 2)Study completedNCT01091454
What this trial is testing

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Alliance for Clinical Trials in Oncology 48
Next Page